'Novel' Disclosure Issue Not Ready For Del. Supreme Court
The Delaware Supreme Court on Monday refused to revive a suit by an investor challenging DAVA Pharmaceuticals Inc.'s $600 million sale to Endo Pharmaceuticals Inc., ruling that the "novel" question of...To view the full article, register now.
Already a subscriber? Click here to view full article